These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16450835)

  • 1. GyrA mutations in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa in a Silesian Hospital in Poland.
    Wydmuch Z; Skowronek-Ciołek O; Cholewa K; Mazurek U; Pacha J; Kepa M; Idzik D; Wojtyczka RD
    Pol J Microbiol; 2005; 54(3):201-6. PubMed ID: 16450835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon.
    Salma R; Dabboussi F; Kassaa I; Khudary R; Hamze M
    J Infect Chemother; 2013 Feb; 19(1):77-81. PubMed ID: 22821356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
    Pasquali F; Rossi M; Manfreda G; Zanoni R
    Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland.
    Piekarska K; Gierczyński R; Ławrynowicz-Paciorek M; Kochman M; Jagielski M
    Pol J Microbiol; 2008; 57(2):121-4. PubMed ID: 18646399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
    Beckmann L; Müller M; Luber P; Schrader C; Bartelt E; Klein G
    J Appl Microbiol; 2004; 96(5):1040-7. PubMed ID: 15078520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.
    Wang LH; Cheng H; Hu FL; Li J
    World J Gastroenterol; 2010 May; 16(18):2272-7. PubMed ID: 20458765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.
    Yonezawa M; Takahata M; Matsubara N; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1970-2. PubMed ID: 8540700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance, integron carriage, and gyrA and gyrB mutations in Pseudomonas aeruginosa isolated from dogs with otitis externa and pyoderma in Brazil.
    Arais LR; Barbosa AV; Carvalho CA; Cerqueira AM
    Vet Dermatol; 2016 Apr; 27(2):113-7e31. PubMed ID: 26833540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
    Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.
    Shultz TR; White PA; Tapsall JW
    Antimicrob Agents Chemother; 2005 May; 49(5):1753-60. PubMed ID: 15855492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli.
    Alonso R; Mateo E; Girbau C; Churruca E; Martinez I; Fernández-Astorga A
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4886-8. PubMed ID: 15561873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
    Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism.
    Ip M; Chau SS; Chi F; Qi A; Lai RW
    J Clin Microbiol; 2006 Mar; 44(3):970-5. PubMed ID: 16517885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.